Squarepoint’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,491
Closed -$1.63M 4002
2021
Q1
$1.63M Buy
+7,491
New +$1.41M 0.01% 1185
2020
Q4
Sell
-4,225
Closed -$411K 3418
2020
Q3
$411K Sell
4,225
-3,580
-46% -$412K 0.01% 1581
2020
Q2
$958K Sell
7,805
-97
-1% -$11K 0.02% 970
2020
Q1
$692K Buy
7,902
+1,754
+29% +$186K 0.02% 881
2019
Q4
$643K Sell
6,148
-24,728
-80% -$2.77M ﹤0.01% 1611
2019
Q3
$3.55M Sell
30,876
-8,140
-21% -$1.24M 0.03% 593
2019
Q2
$6.73M Buy
39,016
+35,263
+940% +$6.1M 0.07% 348
2019
Q1
$633K Sell
3,753
-4,682
-56% -$697K 0.01% 1360
2018
Q4
$821K Buy
8,435
+4,103
+95% +$538K 0.01% 1003
2018
Q3
$748K Buy
+4,332
New +$625K 0.01% 1125
2017
Q4
Sell
-2,068
Closed -$210K 2430
2017
Q3
$210K Buy
+2,068
New +$221K ﹤0.01% 1363

Other funds holding GWPH

Squarepoint's GWPH Position: Q2 2021 in Review

Squarepoint sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 7,491 shares — an estimated $1.63M sold.

Squarepoint first reported a position in GWPH in Q3 2017 and held it in 11 quarters. The position peaked at $6.73M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Squarepoint reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 7,491 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.63M.
  • Squarepoint first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 11 quarters.
  • Squarepoint's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.73M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.